XML 45 R33.htm IDEA: XBRL DOCUMENT v3.25.1
Revenue Recognition - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Disaggregation of Revenue [Line Items]      
Net sales $ 5,866 $ 5,243  
Contract liabilities 1,028   $ 978
Other Orthopedics - Enabling Technologies      
Disaggregation of Revenue [Line Items]      
Net sales 29 31  
Neuro Cranial - Interventional Spine      
Disaggregation of Revenue [Line Items]      
Net sales $ 118 $ 98  
Customer Lease Agreements | Revenue Benchmark | Product Concentration Risk      
Disaggregation of Revenue [Line Items]      
Concentration risk (as a percent) 4.00% 4.00%